
Three medications with approval for long-term use in the treatment of obesity are currently available in the United zzso zzso zzso Food and Drug Administration zzso approved in zzso zzso zzso approved in zzso and zzso (available in Europe and given zzso zzso status in 2006 and expected to be marketed in 2007) represent modern approaches to medications used zzso for weight zzso As demonstrated in large clinical trials of 2 to 4 years' zzso these medications significantly increase weight loss compared with zzso weight loss with these drugs reaches a zzso between 20 and 28 zzso weight loss, averaged zzso with the zzso contributing zzso of zzso Weight maintenance is demonstrated as long as adherence to medication zzso All medications have side effects that need to be zzso For zzso there is a rise in blood pressure and heart rate that may require zzso of the drug in a small percent of zzso For zzso zzso produces the principal gastrointestinal side zzso zzso appears to have a favorable safety and zzso zzso zzso and gastrointestinal symptoms are the chief zzso issue, but they are usually zzso In addition there are several drugs and drug combinations in phase 2 or phase 2 trials that will be reported on in the coming zzso 

